Citigroup’s Xenon Pharmaceuticals XENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.14M Buy
36,290
+29,261
+416% +$916K ﹤0.01% 2440
2025
Q1
$236K Buy
7,029
+581
+9% +$19.5K ﹤0.01% 3345
2024
Q4
$253K Buy
6,448
+2,800
+77% +$110K ﹤0.01% 3443
2024
Q3
$144K Sell
3,648
-190
-5% -$7.48K ﹤0.01% 3813
2024
Q2
$150K Buy
3,838
+1,425
+59% +$55.6K ﹤0.01% 3305
2024
Q1
$104K Sell
2,413
-591
-20% -$25.4K ﹤0.01% 3540
2023
Q4
$138K Buy
3,004
+138
+5% +$6.36K ﹤0.01% 3341
2023
Q3
$97.9K Sell
2,866
-1,288
-31% -$44K ﹤0.01% 3248
2023
Q2
$160K Sell
4,154
-3,663
-47% -$141K ﹤0.01% 3341
2023
Q1
$280K Buy
7,817
+6,008
+332% +$215K ﹤0.01% 2929
2022
Q4
$71.3K Buy
1,809
+92
+5% +$3.63K ﹤0.01% 3473
2022
Q3
$62K Sell
1,717
-201
-10% -$7.26K ﹤0.01% 3592
2022
Q2
$58K Sell
1,918
-100,557
-98% -$3.04M ﹤0.01% 3799
2022
Q1
$3.13M Buy
102,475
+100,174
+4,353% +$3.06M ﹤0.01% 1439
2021
Q4
$72K Sell
2,301
-328
-12% -$10.3K ﹤0.01% 4138
2021
Q3
$40K Sell
2,629
-371
-12% -$5.65K ﹤0.01% 4123
2021
Q2
$56K Buy
3,000
+2,039
+212% +$38.1K ﹤0.01% 4098
2021
Q1
$17K Sell
961
-445
-32% -$7.87K ﹤0.01% 4687
2020
Q4
$22K Buy
1,406
+1,114
+382% +$17.4K ﹤0.01% 4580
2020
Q3
$3K Sell
292
-4,647
-94% -$47.7K ﹤0.01% 4866
2020
Q2
$62K Buy
+4,939
New +$62K ﹤0.01% 3683
2020
Q1
Sell
-1,352
Closed -$18K 5219
2019
Q4
$18K Buy
1,352
+674
+99% +$8.97K ﹤0.01% 4531
2019
Q3
$6K Sell
678
-321
-32% -$2.84K ﹤0.01% 4749
2019
Q2
$10K Buy
999
+246
+33% +$2.46K ﹤0.01% 4756
2019
Q1
$8K Buy
753
+153
+26% +$1.63K ﹤0.01% 4805
2018
Q4
$4K Hold
600
﹤0.01% 4811
2018
Q3
$8K Sell
600
-100
-14% -$1.33K ﹤0.01% 4772
2018
Q2
$6K Hold
700
﹤0.01% 4721
2018
Q1
$3K Hold
700
﹤0.01% 4715
2017
Q4
$2K Hold
700
﹤0.01% 4820
2017
Q3
$2K Hold
700
﹤0.01% 4525
2017
Q2
$2K Hold
700
﹤0.01% 4594
2017
Q1
$3K Hold
700
﹤0.01% 4600
2016
Q4
$5K Hold
700
﹤0.01% 4668
2016
Q3
$6K Hold
700
﹤0.01% 4613
2016
Q2
$4K Hold
700
﹤0.01% 4750
2016
Q1
$5K Hold
700
﹤0.01% 4954
2015
Q4
$6K Hold
700
﹤0.01% 4919
2015
Q3
$6K Buy
700
+649
+1,273% +$5.56K ﹤0.01% 4580
2015
Q2
$1K Buy
+51
New +$1K ﹤0.01% 5378